Study of Dapansutrile Capsules in Heart Failure

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 16, 2018

Primary Completion Date

November 21, 2019

Study Completion Date

November 21, 2019

Conditions

Systolic Heart Failure

Interventions

DRUG

dapansutrile capsules

Hard opaque capsules containing 100 mg of API.

DRUG

Placebo capsules

Hard opaque capsules containing 0 mg of API.

Trial Locations (1)

Virginia Commonwealth University - Pauley Heart Center, Richmond